Upgrade to SI Premium - Free Trial

Progenics Pharma (PGNX) Announces David Mims as Interim CEO

November 21, 2019 4:12 PM
Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) today announced its Board of Directors has appointed David W. Mims as interim Chief Executive ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Management Changes Management Comments

Next Articles